Health Law Alliance recently secured a favorable outcome for a California independent pharmacy after OptumRx rescinded its decision to terminate the pharmacy from participation in its provider networks. The decision followed a comprehensive appeal process during which the pharmacy addressed OptumRx's concerns regarding certain operational and compliance-related issues identified during an audit and investigation. As a result of the appeal, the pharmacy was permitted to remain in-network and continue providing services to OptumRx beneficiaries.
The matter illustrates the significant challenges pharmacies face when responding to PBM audits and investigations, as well as the importance of timely and thorough responses when a network termination is proposed.
The Basis for the Proposed Termination
According to OptumRx, the proposed termination arose from findings related to the pharmacy's inventory management and billing practices. Specifically, OptumRx identified concerns regarding inventory shortages, documentation associated with inventory transfers, inventory reconciliation procedures, and certain NDC billing issues. OptumRx took the position that these issues raised concerns regarding the pharmacy's compliance with its contractual obligations and network participation requirements.
As is often the case in PBM audits, the alleged deficiencies were not limited to a single transaction or isolated claim. Rather, OptumRx's concerns centered on broader operational processes and controls, including the pharmacy's ability to maintain adequate inventory records, document inventory movement between locations, and ensure accurate billing practices. Based upon these findings, OptumRx initially determined that termination from its provider networks was warranted.
For an independent pharmacy, the loss of participation in a major PBM network can have substantial consequences. Network termination may impact patient access, disrupt ongoing patient and provider relationships, reduce prescription volume, and create significant operational and financial challenges. As a result, pharmacies facing termination often have only a limited opportunity to present evidence, provide explanations, and demonstrate compliance before a final decision is rendered.
The Appeal Process
Following receipt of the termination notice, the pharmacy, through its PBM audit attorneys, undertook a comprehensive review of the findings and submitted an appeal challenging the proposed termination. As part of that process, the pharmacy addressed OptumRx's concerns regarding inventory controls, inventory documentation, proof of inventory transfers, and billing practices.
The appeal also focused on the pharmacy's operational procedures and compliance efforts. The pharmacy provided information regarding its inventory management protocols, recordkeeping practices, and corrective measures designed to strengthen compliance and prevent similar issues from occurring in the future. In addition, the pharmacy worked to demonstrate its commitment to maintaining accurate records, implementing appropriate controls, and complying with applicable network requirements.
Following its review of the appeal materials and supporting documentation, OptumRx ultimately rescinded the termination decision. Although OptumRx required the pharmacy to implement additional policies and procedures relating to inventory management, documentation, and billing compliance, the pharmacy was permitted to remain in-network rather than being removed from participation.
Lessons for Pharmacies Facing PBM Audits and Terminations
This matter serves as a reminder that a proposed PBM network termination is not always the final outcome. Many termination decisions arise from audit findings involving inventory discrepancies, documentation deficiencies, billing concerns, or other operational issues that may be capable of explanation, clarification, or remediation.
PBMs frequently require pharmacies to respond within short timeframes and often request extensive supporting documentation. Consequently, pharmacies that receive audit findings, corrective action requests, fraud, waste and abuse investigations, or termination notices should promptly evaluate the allegations and develop a comprehensive response strategy. Early intervention can be critical to preserving appeal rights, gathering supporting evidence, and addressing concerns before a termination becomes final.
How HLA Can Help
Health Law Alliance represents pharmacies nationwide in matters involving PBM audits, network terminations, fraud, waste and abuse investigations, PBM credentialing disputes, and other healthcare regulatory proceedings. Our healthcare defense attorneys routinely assist clients in responding to complex PBM allegations, developing corrective action plans, preparing appeal submissions, and protecting continued network participation. If your pharmacy has received an audit finding or a termination letter from OptumRx, Express Scripts, CVS Caremark, Prime Therapeutics, Humana, or another PBM, our team can help evaluate your options and develop a strategy tailored to your specific circumstances. Contact us today for a free evaluation.
